Astrocyte elevated gene-1 activates MMP9 to increase invasiveness of colorectal cancer

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6679-6685

  Song, Hongtao ^a   Tian, Zhennan ^a   Qin, Yu ^a   Yao, Guodong ^a   Fu, Songbin ^a   Geng, Jingshu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Astrocyte elevated gene 1 (AEG 1); Cancer invasiveness; Cancer metastasis; Colorectal cancer; MMP9

Indexed keywords

GELATINASE B; SMALL INTERFERING RNA;

ARTICLE; ASTROCYTE ELEVATED GENE 1; CACO 2 CELL LINE; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME RELEASE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GENE; TUMOR INVASION;

CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84905003941     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1883-3     Document Type: Article

References (40)

1. East JE, Dekker E. Colorectal cancer diagnosis in 2012: a new focus for CRC prevention-more serration, less inflammation. Nat Rev Gastroenterol Hepatol. 2013;10:69-70.
2. Van Schaeybroeck S, Allen WL, Turkington RC, Johnston PG. Implementing prognostic and predictive biomarkers in CRC clinical trials. Nat Rev Clin Oncol. 2011;8:222-32.
3. Labianca R, Beretta GD, Mosconi S, Pessi MA, Milesi L. The development of clinical research in CRC. Ann Oncol. 2005;16 Suppl 4:iv3-iv43.
4. Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. Cloning and characterization of hiv-1-inducible astrocyte elevated gene-1, aeg-1. Gene. 2005;353:8-15. (Pubitemid 40805356)
5. Boukerche H, Su ZZ, Kang DC, Fisher PB. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization. Gene. 2004;343:191-201. (Pubitemid 39551043)
6. Su ZZ, Chen Y, Kang DC, Chao W, Simm M, Volsky DJ, et al. Customized rapid subtraction hybridization (rash) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene. 2003;306:67-78. (Pubitemid 36351396)
7. Su ZZ, Leszczyniecka M, Kang DC, Sarkar D, Chao W, Volsky DJ, et al. Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (eaat2). Proc Natl Acad Sci U S A. 2003;100:1955-60. (Pubitemid 36254555)
8. Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with hiv-1 or exposure to hiv-1 envelope glycoprotein by rapid subtraction hybridization, rash. Oncogene. 2002;21:3592-602. (Pubitemid 34587691)
9. Huang S, Wu B, Li D, Zhou W, Deng G, Zhang K, et al. Knockdown of astrocyte elevated gene-1 inhibits tumor growth and modifies microRNAs expression profiles in human colorectal cancer cells. Biochem Biophys Res Commun. 2014;444:338-45.
10. Huang K, Li LA, Meng Y, You Y, Fu X, Song L. High expression of astrocyte elevated gene-1 (aeg-1) is associated with progression of cervical intraepithelial neoplasia and unfavorable prognosis in cervical cancer. World J Surg Oncol. 2013;11:297.
11. Guo J, Xia B, Meng F, Lou G. Mir-137 suppresses cell growth in ovarian cancer by targeting aeg-1. Biochem Biophys Res Commun. 2013;441:357-63.
12. Kim JY, Welsh EA, Oguz U, Fang B, Bai Y, Kinose F, et al. Dissection of tbk1 signaling via phosphoproteomics in lung cancer cells. Proc Natl Acad Sci U S A. 2013;110:12414-9.
13. Liu K, Guo L, Miao L, Bao W, Yang J, Li X, et al. Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer a549 cells. Anticancer Drugs. 2013;24:494-503.
14. Ke ZF, Mao X, Zeng C, He S, Li S, Wang LT. Aeg-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis. Med Oncol. 2013;30:383.
15. Gnosa S, Shen YM, Wang CJ, Zhang H, Stratmann J, Arbman G, et al. Expression of aeg-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines. J Transl Med. 2012;10:109.
16. Zhang X, Zhang N, Zhang MX. Astrocyte elevated gene-1 induces breast cancer proliferation and invasion through upregulating her2/neu expression. Chin Med J (Engl). 2011;124:3546-50.
17. Sun S, Ke Z, Wang F, Li S, Chen W, Han A, et al. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer andmediates itsmetastasis through up-regulation of matrix metalloproteinase-9 expression. Hum Pathol. 2012;43:1051-60.
18. Ying Z, Li J, Li M. Astrocyte elevated gene 1: Biological functions and molecular mechanism in cancer and beyond. Cell Biosci. 2011;1:36.
19. He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, et al. Microrna-375 targets aeg-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2012;31:3357-69.
20. Luparello C, Longo A, Vetrano M. Exposure to cadmium chloride influences astrocyte-elevated gene-1 (aeg-1) expression in mdamb231 human breast cancer cells. Biochimie. 2012;94:207-13.
21. Wang C, Yang Q. Astrocyte elevated gene-1 and breast cancer (review). Oncol Lett. 2011;2:399-405.
22. Song H, Li C, Lu R, Zhang Y, Geng J. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer. 2010;20:1188-96.
23. Li C, Li R, Song H, Wang D, Feng T, Yu X, et al. Significance of aeg-1 expression in correlation with vegf, microvessel density and clinicopathological characteristics in triple-negative breast cancer. J Surg Oncol. 2011;103:184-92.
24. Jian-bo X, Hui W, Yu-long H, Chang-hua Z, Long-juan Z, Shi-rong C, et al. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol. 2011;28:455-62.
25. Hu G, Wei Y, Kang Y. The multifaceted role of mtdh/aeg-1 in cancer progression. Clin Cancer Res. 2009;15:5615-20.
26. Song L, Li W, Zhang H, Liao W, Dai T, Yu C, et al. Over-expression of aeg-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol. 2009;219:317-26.
27. Li J, Yang L, Song L, Xiong H, Wang L, Yan X, et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor foxo1. Oncogene. 2009;28:3188-96.
28. Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res. 2008;14:3319-26.
29. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of foxo3a activity. Oncogene. 2007;26:7647-55. (Pubitemid 350224215)
30. Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (aeg-1) is a target gene of oncogenic ha-ras requiring phosphatidylinositol 3-kinase and c-myc. Proc Natl Acad Sci U S A. 2006;103:17390-5. (Pubitemid 44788979)
31. Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through pi3k-akt signaling. Oncogene. 2008;27:1114-21. (Pubitemid 351253177)
32. Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB. Molecular basis of nuclear factor-kappab activation by astrocyte elevated gene-1. Cancer Res. 2008;68:1478-84. (Pubitemid 351346856)
33. Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K, et al. Activation of the nuclear factor kappab pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006;66:1509-16. (Pubitemid 43259932)
34. Yoo BK, Emdad L, Su ZZ, Villanueva A, Chiang DY, Mukhopadhyay ND, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 2009;119:465-77.
35. Li C, Li Y, Wang X, Wang Z, Cai J, Wang L, et al. Elevated expression of astrocyte elevated gene-1 (aeg-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages iii-iv serous ovarian carcinoma. Histopathology. 2012;60:953-63.
36. Song H, Li C, Li R, Geng J. Prognostic significance of aeg-1 expression in colorectal carcinoma. Int J Colorectal Dis. 2010;25:1201-9.
37. Li C, Liu J, Lu R, Yu G, Wang X, Zhao Y, et al. Aeg-1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. Int J Gynecol Cancer. 2011;21:602-8.
38. Li C, Chen K, Cai J, Shi QT, Li Y, Li L, Song H, Qiu H, Qin Y, Geng JS. Astrocyte elevated gene-1: a novel independent prognostic biomarker for metastatic ovarian tumors. Tumour Biol 2013
39. von Kleist S, Chany E, Burtin P, King M, Fogh J. Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst. 1975;55:555-60.
40. Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK, Dash R, et al. Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther. 2010;9:79-88.